Result: Risk Minimisation Materials for medicines starting with the letter O
Olumiant
Eli Lilly and Company Limited

Olumiant 2 mg and 4 mg Film-Coated Tablets guidance for Healthcare Professionals for Atopic Dermatitis
Important Risk Minimization information for healthcare professionals prescribing Olumiant for the treatment of Atopic Dermatitis.
For Healthcare Professionals

Olumiant 2 mg and 4 mg Film-Coated Tablets guidance for Healthcare Professionals for Rheumatoid Arthritis
Important Risk Minimization information for healthcare professionals prescribing Olumiant for the treatment of Rheumatoid Arthritis.
For Healthcare Professionals

Olumiant 2 mg and 4 mg Film-Coated Tablets Patient Alert Card
Olumiant 2 mg and 4 mg Film-Coated Tablets Patient Alert Card containing important safety information for patients.
Onpattro
Alnylam UK Ltd

Onpattro (patisiran) Educational Material for Healthcare Professionals
Educational Material for Healthcare Professionals to ensure safe use of Onpattro in the home setting.
For Healthcare Professionals

Onpattro (patisiran) Educational Material for Patients
Educational Material for patients for safe use of Onpattro in the home.
OPDIVO
Bristol-Myers Squibb Pharmaceuticals limited

Opdivo (nivolumab) Patient Alert Card
The provision of this card to patients is required by the terms of the Marketing Authorisation. Please ensure that you carry this card with you at all times and that you have read and understood this information as it contains important safety information that you need to be aware of before, during and after treatment with nivolumab or nivolumab in combination with ipilimumab. This card was updated in July 2020. Changes to the card include design/editorial updates, removal of the black inverted triangle symbol (and associated wording) and an updated reporting of side effects statement.
Opsumit
Janssen-Cilag Ltd


Opsumit cover letter for HCP
Notification of updated risk management materials for Opsumit (macitentan).
For Healthcare Professionals

Opsumit HCP Brochure UK
Introduction to Opsumit, what its used for, indication and how it should be used
For Healthcare Professionals

Opsumit Patient Alert Card
It is important that you report immediately to your prescribing doctor any pregnancy or side effects that may occur during treatment with Opsumit.
For Healthcare Professionals


prescribers Checklist
Checklist for the physician before prescribing Opsumit to the patient.
For Healthcare Professionals
Oruvail
SANOFI

Oruvail Gel- Checklist for Patients
For hard copies please contact our medical information department at 0800 035 2525 or email [email protected]

Oruvail Gel -Checklist for prescriber
For hard copies please contact our medical information department at 0800 035 2525 or email [email protected]
For Healthcare Professionals
Ozurdex
Allergan Ltd

Ozurdex - Patient Guide
A patient guide to OZURDEX therapy